René Russo
2020 - Xilio Therapeutics
In 2020, René Russo earned a total compensation of $2.5M as President and Chief Executive Officer at Xilio Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $182,250 |
|---|---|
| Option Awards | $854,485 |
| Salary | $450,000 |
| Stock Awards | $1,020,866 |
| Other | $633 |
| Total | $2,508,234 |
Russo received $1M in stock awards, accounting for 41% of the total pay in 2020.
Russo also received $182.3K in non-equity incentive plan, $854.5K in option awards, $450K in salary and $633 in other compensation.
Rankings
In 2020, René Russo's compensation ranked 4,543rd out of 13,090 executives tracked by ExecPay. In other words, Russo earned more than 65.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,543 out of 13,090 | 65th |
Division Manufacturing | 1,836 out of 5,621 | 67th |
Major group Chemicals And Allied Products | 715 out of 2,254 | 68th |
Industry group Drugs | 613 out of 1,954 | 69th |
Industry Pharmaceutical Preparations | 463 out of 1,459 | 68th |
Source: SEC filing on April 26, 2022.
Russo's colleagues
We found one more compensation record of an executive who worked with René Russo at Xilio Therapeutics in 2020.
2020
Martin Huber
Xilio Therapeutics